Latest filing published 05 May 2026 for Aclaris Therapeutics, Inc., €35k. Read the official filing
No signal scores available.
Jesse Wayne Hall appears in our data through filings on Aclaris Therapeutics, Inc. shares, published by SEC (Form 4). Altogether 2 filings, all relating to 1 May 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 5 May 2026, reports a share grant of €35k in Aclaris Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations